Tamoxifen-related endocrine symptoms in Chinese patients with breast cancer: Study protocol clinical trial (SPIRIT Compliant)

BACKGROUND: Breast cancer is the most prevalent cancer in females and disease recurrence remains a significant problem. To prevent recurrence, tamoxifen is prescribed for at least 5 years. However, among patients who receive tamoxifen, individual responses are highly variable. These responses are af...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Carmen Wing Han, Miaskowski, Christine, McCarthy, Alexandra, Waye, Mary Miu Yee, Yeo, Winnie, So, Winnie Kwok Wai, Choi, Kai Chow, Tsui, Stephen Kwok Wing, Chan, Judy Yuet Wa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034730/
https://www.ncbi.nlm.nih.gov/pubmed/32080081
http://dx.doi.org/10.1097/MD.0000000000019083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034730/
https://www.ncbi.nlm.nih.gov/pubmed/32080081
http://dx.doi.org/10.1097/MD.0000000000019083

Ejemplares similares